United States Drugs for Osteoarthritis Pain Market Report 2017

$3,800$7,600

Publisher : QY Research ReportsPublication Date : January 13, 2017
Number of Pages : 115Category : Pharmaceuticals
    Single User $3,800
    Global/Corporate License $7,600
Want to have a look at Sample?
Request Sample
Want to Check Today's Discount?
Enquiry for Discount

Product Description

Notes:
Sales, means the sales volume of Drugs for Osteoarthritis Pain
Revenue, means the sales value of Drugs for Osteoarthritis Pain

This report studies sales (consumption) of Drugs for Osteoarthritis Pain in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
CrystalGenomics
Cytori Therapeutics
Daiichi Sankyo
Eli Lilly
Endo Pharmaceuticals Holdings
Horizon Pharma
ICeutica
Iroko Pharmaceuticals
Merck
Nuvo Research
Regeneron Pharmaceuticals
Sanofi
SantoSolve
Techfields Pharma
Winston Pharmaceuticals
Yooyoung Pharmaceutical
Zynerba Pharmaceuticals

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
OTC
Prescription
Split by applications, this report focuses on sales, market share and growth rate of Drugs for Osteoarthritis Pain in each application, can be divided into
Hospital
Clinics
Household

Additional Information

Country

United States

Region

North America

Published Year

2017

Publisher

QY Research Reports

Category Fillter

Life Sciences

Table of Contents

United States Drugs for Osteoarthritis Pain Market Report 2017
1 Drugs for Osteoarthritis Pain Overview
1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain
1.2.1 OTC
1.2.2 Prescription
1.3 Application of Drugs for Osteoarthritis Pain
1.3.1 Hospital
1.3.2 Clinics
1.3.3 Household
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Drugs for Osteoarthritis Pain (2011-2021)
1.4.1 United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)
1.4.2 United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)

2 United States Drugs for Osteoarthritis Pain Competition by Manufacturers
2.1 United States Drugs for Osteoarthritis Pain Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs for Osteoarthritis Pain Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs for Osteoarthritis Pain Average Price by Manufactures (2015 and 2016)
2.4 Drugs for Osteoarthritis Pain Market Competitive Situation and Trends
2.4.1 Drugs for Osteoarthritis Pain Market Concentration Rate
2.4.2 Drugs for Osteoarthritis Pain Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Drugs for Osteoarthritis Pain Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Drugs for Osteoarthritis Pain Sales and Market Share by States (2011-2016)
3.2 United States Drugs for Osteoarthritis Pain Revenue and Market Share by States (2011-2016)
3.3 United States Drugs for Osteoarthritis Pain Price by States (2011-2016)

4 United States Drugs for Osteoarthritis Pain Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016)
4.2 United States Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
4.3 United States Drugs for Osteoarthritis Pain Price by Type (2011-2016)
4.4 United States Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2011-2016)

5 United States Drugs for Osteoarthritis Pain Sales (Volume) by Application (2011-2016)
5.1 United States Drugs for Osteoarthritis Pain Sales and Market Share by Application (2011-2016)
5.2 United States Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 United States Drugs for Osteoarthritis Pain Manufacturers Profiles/Analysis
6.1 Abbott Laboratories
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.1.2.1 OTC
6.1.2.2 Prescription
6.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
6.2.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.2.2.1 OTC
6.2.2.2 Prescription
6.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Novartis International
6.3.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.3.2.1 OTC
6.3.2.2 Prescription
6.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.4.2.1 OTC
6.4.2.2 Prescription
6.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 AbbVie
6.5.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.5.2.1 OTC
6.5.2.2 Prescription
6.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
6.6 Abiogen Pharma
6.6.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.6.2.1 OTC
6.6.2.2 Prescription
6.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.6.4 Main Business/Business Overview
6.7 Afferent Pharmaceuticals
6.7.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.7.2.1 OTC
6.7.2.2 Prescription
6.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.7.4 Main Business/Business Overview
6.8 Astellas Pharma
6.8.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.8.2.1 OTC
6.8.2.2 Prescription
6.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.8.4 Main Business/Business Overview
6.9 BioDelivery Sciences International
6.9.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.9.2.1 OTC
6.9.2.2 Prescription
6.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.9.4 Main Business/Business Overview
6.10 CrystalGenomics
6.10.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
6.10.2.1 OTC
6.10.2.2 Prescription
6.10.3 CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
6.10.4 Main Business/Business Overview
6.11 Cytori Therapeutics
6.12 Daiichi Sankyo
6.13 Eli Lilly
6.14 Endo Pharmaceuticals Holdings
6.15 Horizon Pharma
6.16 ICeutica
6.17 Iroko Pharmaceuticals
6.18 Merck
6.19 Nuvo Research
6.20 Regeneron Pharmaceuticals
6.21 Sanofi
6.22 SantoSolve
6.23 Techfields Pharma
6.24 Winston Pharmaceuticals
6.25 Yooyoung Pharmaceutical
6.26 Zynerba Pharmaceuticals

7 Drugs for Osteoarthritis Pain Manufacturing Cost Analysis
7.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Drugs for Osteoarthritis Pain Market Forecast (2016-2021)
11.1 United States Drugs for Osteoarthritis Pain Sales, Revenue Forecast (2016-2021)
11.2 United States Drugs for Osteoarthritis Pain Sales Forecast by Type (2016-2021)
11.3 United States Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021)
11.4 Drugs for Osteoarthritis Pain Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source


Tables and Figures

List of Tables and Figures _
_
Figure Picture of Drugs for Osteoarthritis Pain_
Table Classification of Drugs for Osteoarthritis Pain_
Figure United States Sales Market Share of Drugs for Osteoarthritis Pain by Type in 2015_
Figure OTC Picture_
Figure Prescription Picture_
Table Application of Drugs for Osteoarthritis Pain_
Figure United States Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2015_
Figure Hospital Examples_
Figure Clinics Examples_
Figure Household Examples_
Figure United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)_
Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)_
Table United States Drugs for Osteoarthritis Pain Sales of Key Manufacturers (2015 and 2016)_
Table United States Drugs for Osteoarthritis Pain Sales Share by Manufacturers (2015 and 2016)_
Figure 2015 Drugs for Osteoarthritis Pain Sales Share by Manufacturers_
Figure 2016 Drugs for Osteoarthritis Pain Sales Share by Manufacturers_
Table United States Drugs for Osteoarthritis Pain Revenue by Manufacturers (2015 and 2016)_
Table United States Drugs for Osteoarthritis Pain Revenue Share by Manufacturers (2015 and 2016)_
Table 2015 United States Drugs for Osteoarthritis Pain Revenue Share by Manufacturers_
Table 2016 United States Drugs for Osteoarthritis Pain Revenue Share by Manufacturers_
Table United States Market Drugs for Osteoarthritis Pain Average Price of Key Manufacturers (2015 and 2016)_
Figure United States Market Drugs for Osteoarthritis Pain Average Price of Key Manufacturers in 2015_
Figure Drugs for Osteoarthritis Pain Market Share of Top 3 Manufacturers_
Figure Drugs for Osteoarthritis Pain Market Share of Top 5 Manufacturers_
Table United States Drugs for Osteoarthritis Pain Sales by States (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Sales Share by States (2011-2016)_
Figure United States Drugs for Osteoarthritis Pain Sales Market Share by States in 2015_
Table United States Drugs for Osteoarthritis Pain Revenue and Market Share by States (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Revenue Share by States (2011-2016)_
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by States (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Price by States (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Sales by Type (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Sales Share by Type (2011-2016)_
Figure United States Drugs for Osteoarthritis Pain Sales Market Share by Type in 2015_
Table United States Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Revenue Share by Type (2011-2016)_
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Price by Type (2011-2016)_
Figure United States Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Sales by Application (2011-2016)_
Table United States Drugs for Osteoarthritis Pain Sales Market Share by Application (2011-2016)_
Figure United States Drugs for Osteoarthritis Pain Sales Market Share by Application in 2015_
Table United States Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016)_
Figure United States Drugs for Osteoarthritis Pain Sales Growth Rate by Application (2011-2016)_
Table Abbott Laboratories Basic Information List_
Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table Johnson & Johnson Basic Information List_
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table Novartis International Basic Information List_
Table Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table Novartis International Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table Pfizer Basic Information List_
Table Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table Pfizer Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table AbbVie Basic Information List_
Table AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table AbbVie Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table Abiogen Pharma Basic Information List_
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table Afferent Pharmaceuticals Basic Information List_
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table Astellas Pharma Basic Information List_
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table BioDelivery Sciences International Basic Information List_
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table CrystalGenomics Basic Information List_
Table CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)_
Table CrystalGenomics Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)_
Table Cytori Therapeutics Basic Information List_
Table Daiichi Sankyo Basic Information List_
Table Eli Lilly Basic Information List_
Table Endo Pharmaceuticals Holdings Basic Information List_
Table Horizon Pharma Basic Information List_
Table ICeutica Basic Information List_
Table Iroko Pharmaceuticals Basic Information List_
Table Merck Basic Information List_
Table Nuvo Research Basic Information List_
Table Regeneron Pharmaceuticals Basic Information List_
Table Sanofi Basic Information List_
Table SantoSolve Basic Information List_
Table Techfields Pharma Basic Information List_
Table Winston Pharmaceuticals Basic Information List_
Table Yooyoung Pharmaceutical Basic Information List_
Table Zynerba Pharmaceuticals Basic Information List_
Table Production Base and Market Concentration Rate of Raw Material_
Figure Price Trend of Key Raw Materials_
Table Key Suppliers of Raw Materials_
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain_
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain_
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis_
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015_
Table Major Buyers of Drugs for Osteoarthritis Pain_
Table Distributors/Traders List_
Figure United States Drugs for Osteoarthritis Pain Production and Growth Rate Forecast (2016-2021)_
Figure United States Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)_
Table United States Drugs for Osteoarthritis Pain Production Forecast by Type (2016-2021)_
Table United States Drugs for Osteoarthritis Pain Consumption Forecast by Application (2016-2021)_
Table United States Drugs for Osteoarthritis Pain Sales Forecast by States (2016-2021)_
Table United States Drugs for Osteoarthritis Pain Sales Share Forecast by States (2016-2021)_
_

Pre-sales Enquiry

*Your Name

*Your Email

Company

Designation

*Country

*Phone Number

Enquiry For:

Your Message

The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.

*Enter Code
captcha :

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close